Monoclonal antibody injection prevented COVID-19 during Delta, Omicron

Monoclonal antibody injection shown to prevent COVID-19 during Delta, Omicron The relative risk reduction for participants who received adintrevimab as post-exposure prophylaxis was 75%. CIDRAP

A single injection of the monoclonal antibody (mAb), adintrevimab prevented COVID-19 in the phase 2/3 EVADE trial, finds a study yesterday in Open Forum Infectious Diseases.

...